Literature DB >> 30704788

How feasible is the global elimination of HCV infection?

Stefan Wiktor1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30704788     DOI： 10.1016/S0140-6736(18)32750-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago.

Authors:  Sandra Tilmon; A Aronsohn; B Boodram; L Canary; S Goel; T Hamlish; S Kemble; D S Lauderdale; J Layden; K Lee; A J Millman; N Nelson; K Ritger; I Rodriguez; N Shurupova; J Wolf; D Johnson
Journal:  J Public Health (Oxf)       Date:  2021-06-22       Impact factor: 2.341

2.  Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis.

Authors:  Michael J Zoratti; Ayesha Siddiqua; Rita E Morassut; Dena Zeraatkar; Roger Chou; Judith van Holten; Feng Xie; Eric Druyts
Journal:  EClinicalMedicine       Date:  2020-01-05

3.  Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.

Authors:  Emily Lynch; Gregoire Falq; Chhorvy Sun; Pharm D Tek Bunchhoeung; Helena Huerga; Anne Loarec; Jean-Phillipe Dousset; Tonia Marquardt; Mickael Le Paih; David Maman
Journal:  BMC Infect Dis       Date:  2021-02-26       Impact factor: 3.090

4.  Reported Barriers to Hepatitis C Treatment among Pregnant and Early-Parenting Mothers Undergoing Substance Use Disorder Treatment in One U.S. State.

Authors:  Ayooluwatomiwa Deborah Adekunle; Kathi L Harp; Zaynab G Al-Abdali; Agatha S Critchfield; Sheila Barnhart; Kathleen T Winter
Journal:  Infect Dis Rep       Date:  2021-12-22

Review 5.  Hepatitis C virus: A critical approach to who really needs treatment.

Authors:  Elias Kouroumalis; Argyro Voumvouraki
Journal:  World J Hepatol       Date:  2022-01-27

6.  Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs.

Authors:  Alan Yeung; Norah E Palmateer; John F Dillon; Scott A McDonald; Shanley Smith; Stephen Barclay; Peter C Hayes; Rory N Gunson; Kate Templeton; David J Goldberg; Matthew Hickman; Sharon J Hutchinson
Journal:  J Hepatol       Date:  2021-10-09       Impact factor: 25.083

7.  Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; Georgios Angelidakis; Ying Jiang; Minas Economides; Khalis Mustafayev; Marcel Yibirin; Robert Orlowski; Richard Champlin; Srdan Verstovsek; Issam Raad
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

8.  Association of the Extension for Community Healthcare Outcomes Project With Use of Direct-Acting Antiviral Treatment Among US Adults With Hepatitis C.

Authors:  Linh Tran; Roger Feldman; Thomas Riley; Jeah Jung
Journal:  JAMA Netw Open       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.